BioSpace News Archive

First FDA Approved Potassium Phosphates Injection Expected to Address Previous Market Shortages and Provide Improved Safety Profile as Opposed to Using Unapproved Products

Vivante Health, the leader in digital medicine for gut health and disease, proudly announced a collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop digital predictive biomarkers for chronic diseases.

Leveraging Accumulated Experience in Monitoring Coronavirus Symptoms, Israeli Telehealth Company Releases Solution to Avoid Low-risk Patients Overwhelming Hospitals

CEFALY, the first device of its kind to receive FDA medical clearance for migraine headaches announced a Buy Back program today where customers in the United States and Canada may return their original CEFALY 1 device (C1) and receive a discount off the purchase of a CEFALY DUAL device.

Molecular diagnostics company XCR Diagnostics has successfully completed the verification and validation of its XCR® COVID-19 assay and can now petition the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA).

Altasciences , a CRO in the U.S. and Canada specializing in a flexible, innovative approach to comprehensive early stage drug development, announced today that they have entered into an agreement with Amador Bioscience , a translational and consulting clinical research organization located in China and the U.S. This partnership aims to expand world-class capabilities and resources to promote drug development in China and North America.

SignPath Pharma today confirmed its commitment to developing a treatment for severe viral infections utilizing Lipocurc™, its patented intravenous formulation of liposomal curcumin. SignPath’s Lipocurc™ is an intravenous treatment, proven to be safe in patients, that profoundly suppresses the multiple pro-inflammatory cytokines that cause severe lung damage (ARDS) in patients with COVID-19 infection caused by corona

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on market intelligence solution.

Avalere, an Inovalon company specializing in healthcare research and strategic advisory services, has entered into a collaboration with Corrona, a leader in real-world evidence generation in autoimmune diseases through its independent registry platform

Fund Promotes Social Distancing and Assistance for Needed Services and Products